Home
We want to hear from you!
|
Contact us at enquiries@eaasm.eu to share your experiences of buying medicines online, or receiving medicines from your pharmacist which have seemed out of the ordinary. |
The European Alliance for Access to Safe Medicines (EAASM) is an independent, cross-sector patient safety Alliance campaigning for the exclusion of counterfeit and substandard medicines from the supply chain. Raising public awareness of the issues surrounding counterfeit medicines forms a key part of the activities of the EAASM.
On this website you will find a wealth of information about counterfeit and substandard medicines. Our top tips section will help you to reassure yourself that the prescription medicine you are buying is genuine. Our news section will provide you with the latest news on counterfeit medicines in Europe and around the world as well as updates about the EAASM activities. The EAASM constantly updates and adds useful resources to the website so you can get as much information as possible about obtaining safe medicines.
If you would like to receive any further information or have any questions please email us at:enquiries@eaasm.eu
Packaging Patient Protection
To read the full report, click here
Recommendations for new legislation to combat counterfeit medicines
The European Alliance for Access to Safe Medicines (EAASM) has today submitted a new report to European Parliament, calling for enhanced legislation to improve the protection of Europe’s patients against the intensifying risks and dangers of counterfeit medicines.
Packaging Patient Protection, published by the EAASM in partnership with stakeholders in patient associations, non-governmental organisations and the pharmaceutical industry, is a clear set of recommendations for new laws to combat fake, counterfeit and substandard medicines.
The document delivers seven key recommendations for Europe’s policy-makers, including:
- a legal obligation for any party in the supply chain unpacking a medicine box to (re)apply a minimum level of effective traceable and tamper-proof security technology
- a mechanism to ensure that cost should not, as far as possible, be a prohibitive in the implementation of a universally-supported minimum security provision; however, original manufacturers may choose to supplement this with additional overt or covert security features on particular products
- a means by which patient in Europe may recognise medicines that have been tampered with since issue from the original manufacturer
World Customs Organization (WCO) Secretary General Kunio Mikuriya recently signed a declaration vowing for the 176 Member Customs administrations to combat the counterfeit pharmaceutical industry.
MHRA investigation leads to 6 month prison sentence for sale and supply of fake slimming pills
MEPs have overwhelmingly approved plans for strengthening draft EU legislation aimed at preventing counterfeit medicines from entering the supply chain, with the inclusion of internet drug sales. 
